Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Treatment
Share your love
Eversight Partners with Emmecell for Ocular Therapy Advances
Eversight, a leading non-profit dedicated to the restoration of sight through the recovery, processing, and distribution of corneal tissue, announced a strategic partnership with Emmecell Biotech, a biotechnology company focused on developing novel cell therapies for ocular diseases. This collaboration…
Dr. Arshad Khanani Joins Ophtea as Chief Medical Advisor
Opthea Limited announced Dr. Arshad M. Khanani, MD, MA, FASRS, as its new Chief Medical Advisor. Dr. Khanani, renowned in retina specialization and clinical research, brings a wealth of expertise from his tenure at Sierra Eye Associates and his academic…
A Guide to Eyelid Hygiene: Preventing Common Eye Conditions
Eyelid hygiene is an essential, yet often overlooked, aspect of overall eye health. Neglecting the cleanliness of your eyelids can lead to various conditions, including swollen eyelids, eyelid twitching, styes, eyelid dermatitis, and bumps on the eyelid. Understanding and practicing…
What Is Meibomian Gland Dysfunction?
Meibomian gland dysfunction (MGD) is a common eye disorder that affects the meibomian glands, which are located in the eyelids and produce the oily layer of the tear film. The disorder is characterized by the blockage or dysfunction of these…
Itchy Eyelids: Causes, Treatment and Home Remedies
Itchy eyelids, though common, can be a source of significant discomfort and concern. In this comprehensive guide, we explore the factors contributing to eyelid itchiness, relief strategies, and optimal treatment options to address this common concern. What Causes Itchy Eyelids?…
Blepharoconjunctivitis: Causes, Symptoms and Treatment
Blepharoconjunctivitis is a medical condition characterized by the simultaneous inflammation of the eyelids (blepharitis) and the conjunctiva, which is the membrane covering the white part of the eye and the inner surface of the eyelids. This condition often results in…
Scientist Awarded $300K for AMD Research
Dr. Rajendra Apte, MD, PhD, has been honored with the Research to Prevent Blindness (RPB)/American Macular Degeneration Foundation (AMDF) Catalyst Award for Innovative Research Approaches for Age-Related Macular Degeneration (AMD). This award, amounting to $300,000, underscores Dr. Apte’s dedication and…
FDA Approves XDEMVY for Demodex Blepharitis
Tarsus Pharmaceuticals has received FDA approval for XDEMVY(TM) (lotilaner ophthalmic solution) 0.25% to treat Demodex blepharitis, making it the first and only FDA-approved treatment directly targeting Demodex mites, the underlying cause of the condition. The approval was based on the…
Lupin Launches Bromfenac Ophthalmic Solution in the US
Lupin Limited announced the launch of Bromfenac Ophthalmic Solution, 0.075%. The product has received the green light from the United States Food and Drug Administration (U.S. FDA), marking a crucial milestone for the company’s expansion in the American pharmaceutical market.…
Opthea Completes Enrollment for Wet AMD Trial
Opthea has reached a significant milestone in its quest to combat wet age-related macular degeneration (AMD) with the completion of patient enrollment in the COAST phase 3 pivotal clinical trial. The trial investigates sozinibercept (OPT-302), a promising vascular endothelial growth…